HSV-2: Ayurveda and The Modern Biomedical Picture

HSV-2: Ayurveda and The Modern Biomedical Picture

Herpes Simplex Virus Type 2 — Biomedical Pathogenesis & Ayurvedic Dhatu Framework

🦠

HSV-2: The Modern Biomedical Picture

HSV-2 (Herpes Simplex Virus Type 2) is one of the most common sexually transmitted infections globally. Viral replication occurs in epithelial tissue, and the virus establishes dormancy in sensory neurons, reactivating periodically as localised recurrent lesions. Study 1

Both HSV-1 and HSV-2 typically access the body through the genital or oral mucosa, replicating in the stratified squamous epithelium, where the virus is taken up by unmyelinated sensory nerve fibres. HSV then undergoes retrograde transport to the neuronal cell bodies in the dorsal root ganglia near the spinal cord, where acute infection is followed by lifelong latent infection. Study 4

HSV has two replication cycles — lytic and latent. During lytic replication, HSV produces infectious viral particles to infect other cells, while during latency there is limited gene expression and lack of infectious virus particles. The intrinsic, innate, and adaptive immune responses are key to controlling HSV, and the virus has developed mechanisms to evade them. Study 6

An estimated 520 million people aged 15–49 worldwide have HSV-2 infection, the main cause of genital herpes. Infection with HSV-2 also increases the risk of acquiring and transmitting HIV infection. Study 3

🌿

HSV-2 in Ayurveda: The Disease "Visarpa"

In Ayurvedic classical texts, HSV-2 and related herpes infections are correlated with a condition called Visarpa (also called Parisarpa).

Herpes is called visarpa or parisarpa in Ayurveda and is caused by the Nita group of viruses, which includes herpes zoster virus, HSV-1, and HSV-2. Although herpes lesions appear to be simple, the pain and burning sensation are agonising — it is considered an acute condition which needs immediate treatment. Study 12

In Ayurveda, HSV is often correlated with conditions like Visarpa, Aagantuja Vyadhi (externally caused disease), and Pitta-Kapha dominant skin conditions. These are attributed to Pitta, Kapha, and Rakta imbalance, along with a weakened immune system. Weakened Ojas, stress, and accumulation of toxins (Ama) in the body trigger recurrent outbreaks. Study 15

🧬

The 7 Dhatus Disrupted by HSV-2

All seven Dhatus and the three doshas (Tridosha) are involved in the pathogenesis of Visarpa. Study 16 Below is how each Dhatu is implicated, with cross-references to modern biomedical findings.

Dhatu 1

Rasa Dhatu — Plasma / Lymphatic Fluid

Rasa Dhatu is impaired, leading to weakened lymph flow and diminished immunity. Study 13 In modern terms, this correlates with HSV's disruption of the lymphatic immune response and its ability to evade immune surveillance.

Dhatu 2

Rakta Dhatu — Blood Tissue

Rakta Dhatu is affected by the virus, creating systemic inflammation. Study 13 When aggravated Pitta together with Rakta spreads within the skin, it causes the red swelling that is the hallmark of Visarpa. Study 16 This mirrors the inflammatory cascade seen in HSV-2 outbreaks at mucosal and skin level.

Dhatu 3

Mamsa Dhatu — Muscle / Soft Tissue

Mamsa Dhatu disruption leads to boils, ulcers, and fluid imbalances. Study 13 Kapha and Vata dosha disturbance involves mamsa vaha srotas (channels nourishing muscle tissue), leading to physical tissue destruction visible as blistering and ulceration. Study 16

Dhatu 4

Meda Dhatu — Fat / Connective Tissue

Meda Dhatu is implicated in fluid imbalances during herpes infection. Study 13 The viral envelope of HSV-2 is itself a lipid bilayer; Ayurveda's recognition of Meda disruption aligns conceptually with the virus's interaction with fatty and connective tissues during entry and replication.

Dhatu 5

Asthi Dhatu — Bone / Skeletal Tissue

While less directly implicated for HSV-2 specifically (more relevant in severe disseminated forms), Asthi is considered part of the overall Dhatu chain that becomes progressively weakened as the disease penetrates deeper — reflecting the concept of Dhatu-kshaya (tissue depletion) in chronic or recurrent infections.

Dhatu 6 Most Critical

Majja Dhatu — Bone Marrow / Nervous Tissue

Majja Dhatu is disturbed, manifesting as nervous system disruption and viral latency — the Ayurvedic equivalent of neural latency. Study 13 This is confirmed by modern science: HSV-2 infects nerve endings and translocates by retrograde transport to the nuclei of sensory ganglia, where the viral genome remains for the entire life of the individual. Study 2 The virus "hides" in Majja Dhatu — the deepest nervous tissue — which is precisely why it is so difficult to eradicate.

Dhatu 7

Shukra Dhatu — Reproductive Tissue / Vital Essence

Shukra Dhatu is impaired, leading to compromised fertility, sexual energy, and reproductive strength. Study 13 This is especially relevant for HSV-2, given its primary site of infection is the genital tract, and the virus's dormancy in the sacral ganglia directly oversees the reproductive organs.

Dosha Involvement in HSV-2

HSV-2, which impacts the genital region, primarily involves the Shukragata Srotas (reproductive channels) and the Muladhara (sacral nerve plexus), with symptoms — burning, discharge, ulceration, nerve pain — aligning strongly with Pitta-Vata aggravation and deep Rakta (blood/inflammatory) vitiation. Study 14

  • Vataja Visarpa: Dominated by nerve pain, tremors, and dryness.
  • Pittaja / Agni Visarpa: Dominated by burning sensation, fever, and inflammation.
  • Kaphaja / Sannipatika Visarpa: Chronic, spreading, and harder to cure.
⚠️ Important Note: The Ayurvedic Dhatu framework is a traditional interpretive model, not a biomedically validated clinical system. The correlation between HSV-2's known biological behaviour (nerve latency, immune evasion, mucosal damage) and the disrupted Dhatus is conceptually coherent and intellectually rich — but claims of "curing" herpes through Ayurveda lack the clinical trial evidence that exists for conventional antivirals like acyclovir/valacyclovir. Both systems can be explored together, ideally under qualified practitioners from each tradition.
📚

Studies & References

Study 1 Herpes Genitalis (Herpes Simplex Type 2) – StatPearls
Date: March 13, 2024 Source: NCBI Bookshelf / StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK554427/

A comprehensive clinical review of herpes genitalis caused by HSV-1 and HSV-2, covering pathogen biology, clinical presentation, and treatment. The article describes how viral replication occurs in epithelial tissue and dormancy is established in sensory neurons. It also covers antiviral therapies including acyclovir, valacyclovir, and emerging agents such as valomaciclovir.


↑ Back to top
Study 2 Pathogenesis and Disease – Human Herpesviruses
Date: N/A (classic reference text) Source: NCBI Bookshelf – Human Herpesviruses
https://www.ncbi.nlm.nih.gov/books/NBK47449/

Describes the molecular pathogenesis of HSV-1 and HSV-2, focusing on nerve entry, retrograde transport to sensory ganglia, latency establishment, and reactivation mechanisms. The text explains that the viral genome persists lifelong in sensory neurons in an episomal state. It also covers ocular and cutaneous manifestations of HSV infections in detail.


↑ Back to top
Study 3 Herpes Simplex Virus – WHO Fact Sheet
Date: May 30, 2025 Source: World Health Organization
https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus

Global epidemiological data on HSV-1 and HSV-2 infections from the WHO. Estimates that 520 million people aged 15–49 have HSV-2 infection worldwide as of 2020 data. Notes that HSV-2 infects women almost twice as often as men, and that infection with HSV-2 significantly increases the risk of acquiring and transmitting HIV.


↑ Back to top
Study 4 Herpes Simplex Mechanism
Date: September 27, 2025 Source: News-Medical Life Sciences
https://www.news-medical.net/health/Herpes-Simplex-Mechanism.aspx

Explains the step-by-step cellular mechanism of HSV infection: entry via mucosal membranes, replication in stratified squamous epithelium, uptake by unmyelinated sensory nerve fibres, and retrograde transport to dorsal root ganglia. Describes the lytic-latent cycle and how the immune system controls reactivation at multiple levels. Notes that viral shedding can occur more than a week before or after symptoms.


↑ Back to top
Study 6 Pathogenesis and Virulence of Herpes Simplex Virus
Date: October 2021 Source: Virulence Journal / Taylor & Francis Online
https://www.tandfonline.com/doi/full/10.1080/21505594.2021.1982373

A peer-reviewed review of HSV life cycle, immune evasion strategies, and three key disease manifestations: herpes stromal keratitis, herpes simplex encephalitis, and genital herpes. Covers both lytic replication (producing infectious particles) and latency (limited gene expression, no viral particles). Also discusses the emerging association between HSV-1 infection and Alzheimer's disease.


↑ Back to top
Study 12 Ayurvedic Treatment, Medicines & Remedies for Herpes
Date: February 8, 2023 Source: MyUpchar
https://www.myupchar.com/en/disease/herpes-simplex-virus/ayurveda

Describes the Ayurvedic conceptualisation of herpes as 'Visarpa' caused by the Nita group of viruses. Explains that all seven Dhatus and the Tridoshas are involved in pathogenesis. Classifies Visarpa into types based on dominant dosha: Vataja, Pittaja, Kaphaja, Tridoshaja, Agni, Kardama, and Granthi Visarpa. Details Ayurvedic herbs and treatments including yashtimadhu, arjuna, haritaki, and panchatikta ghrita guggulu.


↑ Back to top
Study 13 Why Modern Medicine Can't Cure Herpes But Ayurveda Can
Date: June 19, 2025 Source: Panaceayur
https://panaceayur.com/why-modern-medicine-cant-cure-herpes-but-ayurveda-can/

Presents the Ayurvedic perspective on HSV as a multi-Dhatu condition, mapping viral behaviour to disruptions in Rasa, Rakta, Mamsa, Meda, Majja, and Shukra Dhatus. Argues that antivirals only suppress active replication and cannot reach latent virus in nerve ganglia. Proposes Ayurvedic Rasayana agents — including Gandhak Rasayan and curcumin — as tools for tissue regeneration and immune restoration.


↑ Back to top
Study 14 HSV-1 vs HSV-2: What's the Difference?
Date: January 13, 2026 Source: Panaceayur
https://panaceayur.com/hsv-1-vs-hsv-2-whats-the-difference/

Compares HSV-1 and HSV-2 across clinical, epidemiological, and Ayurvedic dimensions. HSV-2 is linked to Shukragata Srotas (reproductive channels) and the sacral nerve plexus, with Pitta-Vata aggravation and deep Rakta vitiation. Introduces the concept of 'Nidanarthakara Roga' — dormant disease influencing other conditions — as an Ayurvedic analogue for asymptomatic viral shedding.


↑ Back to top
Study 15 Ayurvedic Treatment for Herpes Simplex Virus (HSV)
Date: July 16, 2025 Source: IAFA (Institute of Applied Food Allergy)
https://www.iafaforallergy.com/disease-a-to-z/herpes-simplex-virus/

Correlates HSV in Ayurveda with Visarpa, Aagantuja Vyadhi, and Pitta-Kapha dominant skin disease. Identifies weakened Ojas, chronic stress, and accumulated Ama (toxins) as triggers for recurrent outbreaks. Recommends detoxification through Virechana and Rakta Mokshana, and herbs including Neem, Haridra, Guduchi, and Manjistha. Also advocates Rasayana therapy for immune restoration.


↑ Back to top
Study 16 Role of Ayurveda in the Management of Genital Herpes & Sarpa Suttu
Date: April 18, 2025 Source: Lybrate / Dr. Chethan Jagalur (BAMS)
https://www.lybrate.com/topic/role-of-ayurveda-in-the-management-of-genital-herpes/...

A clinical Ayurvedic case-study article classifying herpes (Visarpa) as an infectious disease caused by the Nita group of viruses (herpesviruses). Identifies Kapha-Vata dosha disturbance and involvement of Rasa, Rakta, Mamsa, Twak, and Lasika (lymph) Dhatus, as well as Mamsa Vaha and Rasa Vaha Srotas. Provides clinical case details and diagnosis as Agni Visarpa with treatment recommendations.


↑ Back to top
Scroll to Top
MENU
For Radiant Health